PAM
Palisade Asset Management’s Boston Scientific BSX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $388K | Hold |
3,608
| – | – | 0.04% | 162 |
|
2025
Q1 | $364K | Buy |
3,608
+80
| +2% | +$8.07K | 0.04% | 161 |
|
2024
Q4 | $315K | Hold |
3,528
| – | – | 0.03% | 170 |
|
2024
Q3 | $296K | Buy |
+3,528
| New | +$296K | 0.03% | 176 |
|
2024
Q2 | – | Sell |
-2,528
| Closed | -$173K | – | 223 |
|
2024
Q1 | $173K | Buy |
+2,528
| New | +$173K | 0.02% | 203 |
|
2017
Q4 | – | Sell |
-11,900
| Closed | -$347K | – | 163 |
|
2017
Q3 | $347K | Hold |
11,900
| – | – | 0.06% | 117 |
|
2017
Q2 | $330K | Hold |
11,900
| – | – | 0.06% | 117 |
|
2017
Q1 | $296K | Hold |
11,900
| – | – | 0.05% | 120 |
|
2016
Q4 | $257K | Hold |
11,900
| – | – | 0.05% | 126 |
|
2016
Q3 | $283K | Hold |
11,900
| – | – | 0.05% | 118 |
|
2016
Q2 | $278K | Hold |
11,900
| – | – | 0.05% | 121 |
|
2016
Q1 | $224K | Buy |
+11,900
| New | +$224K | 0.04% | 127 |
|
2015
Q4 | – | Sell |
-10,500
| Closed | -$172K | – | 130 |
|
2015
Q3 | $172K | Hold |
10,500
| – | – | 0.04% | 130 |
|
2015
Q2 | $186K | Hold |
10,500
| – | – | 0.04% | 134 |
|
2015
Q1 | $186K | Buy |
+10,500
| New | +$186K | 0.04% | 135 |
|